Roche Molecular Systems Director of Operations Salaries in Oklahoma City, OK
The average Roche Molecular Systems Director of Operations in Oklahoma City, OK earns an estimated $178,835 annually, which includes an estimated base salary of $149,109 with a $29,726 bonus. Roche Molecular Systems' Director of Operations compensation is $38,069 more than the US average for a Director of Operations. Director of Operations salaries at Roche Molecular Systems in Oklahoma City, OK can range from $62,000 - $340,000.
In Oklahoma City, OK, The Operations Department at Roche Molecular Systems earns $4,351 more on average than the Business Development Department.
Last updated a year ago.
- $149,109
- avg. base
- $29,726
- avg. bonus
Director of Operations Salaries at Roche Molecular Systems
In Oklahoma City, OK, Directors of Operations earn $3,571 more than Directors of Operations.
Compensation at Roche Molecular Systems by Department
In Oklahoma City, OK, The Operations Department averages $4,351 more than the Business Development Department, and $4,251 less than the Product Department
Director of Operations Compensation by Gender (All Companies)
The average female Director of Operations at companies similar size to Roche Molecular Systems reported making $178,169, while the average male Director of Operations at similar sized companies reported making $182,882.
Director of Operations Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Director of Operations at companies similar size to Roche Molecular Systems reported making $184,403, while the average African American/Black Director of Operations at similar sized companies reported making $141,003.
How Directors of Operations at Roche Molecular Systems Rate Their Compensation
The majority of Directors of Operations at Roche Molecular Systems believe they're compensated fairly. 100% of Directors of Operations at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
